1. Academic Validation
  2. Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability

Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability

  • Oncogene. 2015 Aug 20;34(34):4531-44. doi: 10.1038/onc.2014.388.
E Martín-Villar 1 2 B Borda-d'Agua 2 P Carrasco-Ramirez 1 J Renart 1 M Parsons 2 M Quintanilla 1 G E Jones 2
Affiliations

Affiliations

  • 1 Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), Madrid, Spain.
  • 2 Randall Division of Cell & Molecular Biophysics, King's College London, London, UK.
Abstract

Invadopodia are actin-rich cell membrane projections used by invasive cells to penetrate the basement membrane. Control of invadopodia stability is critical for efficient degradation of the extracellular matrix (ECM); however, the underlying molecular mechanisms remain poorly understood. Here, we uncover a new role for podoplanin, a transmembrane glycoprotein closely associated with malignant progression of squamous cell carcinomas (SCCs), in the regulation of invadopodia-mediated matrix degradation. Podoplanin downregulation in SCC cells impairs invadopodia stability, thereby reducing the efficiency of ECM degradation. We report podoplanin as a novel component of invadopodia-associated adhesion rings, where it clusters prior to matrix degradation. Early podoplanin recruitment to invadopodia is dependent on lipid rafts, whereas ezrin/moesin proteins mediate podoplanin ring assembly. Finally, we demonstrate that podoplanin regulates invadopodia maturation by acting upstream of the ROCK-LIMK-Cofilin pathway through the control of RhoC GTPase activity. Thus, podoplanin has a key role in the regulation of invadopodia function in SCC cells, controlling the initial steps of Cancer cell invasion.

Figures